Wood Investment Counsel’s Accelerate Diagnostics AXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$5.94M Hold
27,655
0.89% 30
2014
Q2
$7.19M Buy
27,655
+396
+1% +$86.4K 1.07% 30
2014
Q1
$5.95M Hold
27,259
0.96% 29
2013
Q4
$3.33M Hold
27,259
0.53% 30
2013
Q3
$3.65M Buy
27,259
+1,640
+6% +$146K 0.66% 29
2013
Q2
$2.08M Buy
+25,619
New +$1.9M 0.39% 34

Other funds holding AXDX

Wood Investment Counsel's AXDX Position: Q3 2014 in Review

Wood Investment Counsel held its Accelerate Diagnostics (AXDX) position steady in Q3 2014 at 27,655 shares worth $5.94M. The position accounts for 0.89% of the portfolio, ranked #30.

Wood Investment Counsel first reported a position in AXDX in Q2 2013 and has held it in 6 quarters since. The position peaked at $7.19M in Q2 2014. 71 funds tracked by Wall St. Rank hold AXDX as of Q3 2014.

  • Wood Investment Counsel held 27,655 shares of Accelerate Diagnostics worth $5.94M as of Q3 2014.
  • Wood Investment Counsel left its Accelerate Diagnostics share count unchanged in Q3 2014.
  • Accelerate Diagnostics made up 0.89% of Wood Investment Counsel's portfolio in Q3 2014, its #30 holding.
  • Wood Investment Counsel first reported a position in Accelerate Diagnostics in Q2 2013 and has held it in 6 quarters since.
  • Wood Investment Counsel's Accelerate Diagnostics position peaked at $7.19M in Q2 2014.
  • 71 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2014.

Based on Wood Investment Counsel's 13F filing for Q3 2014, filed 27 Oct 2014.